📊 HLYK Key Takeaways
Is HLYK a Good Investment? Thesis Analysis
HealthLynked faces imminent financial distress with negative stockholders' equity of -$5.8M, only $37.1K cash reserves, and operating cash burn of -$1.7M annually. Revenue collapsed 31.3% YoY while the company burns cash at a rate that depletes remaining liquidity in approximately 3 weeks, creating acute solvency risk.
Why Buy HLYK? Key Strengths
- Exceptional gross margin of 90.7% demonstrates viable core unit economics in medical services delivery
- Net loss improved 46.5% YoY suggesting operational cost controls are taking effect
- Healthcare services sector has structural demand tailwinds if company survives liquidity crisis
HLYK Investment Risks to Consider
- Negative equity of -$5.8M means liabilities exceed all assets - company is technically insolvent
- Critical liquidity crisis: $37.1K cash against $7.5M liabilities with monthly burn rate exceeding available cash
- Severe revenue decline of 31.3% YoY with no evidence of stabilization or recovery trajectory
- Negative operating cash flow of -$1.7M and free cash flow margin of -83.1% indicate unsustainable operations
- Current ratio of 0.22x shows inability to service short-term obligations from current assets
Key Metrics to Watch
- Monthly cash burn rate and estimated runway to insolvency/capital injection deadline
- Revenue trend reversal: Whether next quarter stabilizes the -31% YoY decline
- Operating cash flow return to positive: Critical survival metric given current burn
- Capital raise or debt restructuring announcements to address negative equity
- Customer acquisition cost versus lifetime value trends in medical services segment
HLYK Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
HLYK Profitability Ratios
HLYK vs Default Sector
How HealthLynked Corp compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is HLYK Overvalued or Undervalued?
Based on fundamental analysis, HealthLynked Corp has mixed fundamental signals relative to the Default sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
HLYK Balance Sheet & Liquidity
HLYK 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: HealthLynked Corp's revenue has declined by 25% over the 5-year period, indicating business contraction. The most recent EPS of $-2.18 indicates the company is currently unprofitable.
HLYK Growth Metrics (YoY)
HLYK Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $388.5K | -$701.0K | $-0.30 |
| Q2 2025 | $592.4K | -$701.0K | $0.00 |
| Q1 2025 | $774.2K | -$1.1M | $0.00 |
| Q2 2023 | $35.5K | $448.5K | $0.00 |
| Q1 2023 | $16.3K | -$1.2M | N/A |
| Q3 2022 | $1.3M | -$368.0K | $0.00 |
| Q2 2022 | $1.4M | -$505.8K | $0.00 |
| Q1 2022 | $1.4M | -$1.2M | $-0.01 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
HLYK Capital Allocation
HLYK SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for HealthLynked Corp (CIK: 0001680139)
📋 Recent SEC Filings
❓ Frequently Asked Questions about HLYK
What is the AI rating for HLYK?
HealthLynked Corp (HLYK) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.
What are HLYK's key strengths?
Claude: Exceptional gross margin of 90.7% demonstrates viable core unit economics in medical services delivery. Net loss improved 46.5% YoY suggesting operational cost controls are taking effect.
What are the risks of investing in HLYK?
Claude: Negative equity of -$5.8M means liabilities exceed all assets - company is technically insolvent. Critical liquidity crisis: $37.1K cash against $7.5M liabilities with monthly burn rate exceeding available cash.
What is HLYK's revenue and growth?
HealthLynked Corp reported revenue of $2.1M.
Does HLYK pay dividends?
HealthLynked Corp pays dividends, with $2.3M distributed to shareholders in the trailing twelve months.
Where can I find HLYK SEC filings?
Official SEC filings for HealthLynked Corp (CIK: 0001680139) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is HLYK's EPS?
HealthLynked Corp has a diluted EPS of $-1.16.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is HLYK a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, HealthLynked Corp has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is HLYK stock overvalued or undervalued?
Valuation metrics for HLYK: ROE of N/A (sector avg: 15%), net margin of -158.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy HLYK stock in 2026?
Our dual AI analysis gives HealthLynked Corp a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is HLYK's free cash flow?
HealthLynked Corp's operating cash flow is $-1.7M, with capital expenditures of $2.6K. FCF margin is -83.1%.
How does HLYK compare to other Default stocks?
Vs Default sector averages: Net margin -158.8% (avg: 12%), ROE N/A (avg: 15%), current ratio 0.22 (avg: 1.8).